Robert Patrick Mahoney - 14 Aug 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role: Chief Scientific Officer
Signature: /s/ Ryan M. Rourke Reed, Attorney-in-Fact
Issuer symbol: CMRA
Transactions as of: 14 Aug 2023
Transactions value $: $12,504
Form type: 4
Filing time: 15 Aug 2023, 17:15:41 UTC
Previous filing: 16 Feb 2023
Next filing: 28 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRA	Common Stock	Purchase	$12.5K	+20K	+19.12%	$0.63	125K	14 Aug 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.59 to $0.64, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Content

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.59 to $0.64, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.